Insulet (PODD) Stock
NSQ · PODD
140.60
Fundamentals
Market cap
$9.75B
Price / Earnings ratio
26.2x
Price / Sales ratio
3.2x
Price / Book ratio
6.9x
Return on assets
0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Insulet
Insulet is an innovative medical device company. With the mission of improving the lives of people with diabetes and through our revolutionary Omnipod Insulin Management System, we seek to expand the use of insulin pump therapy.
SectorHealthcare
IndustryMedical Devices
Employees5,400
CEOMs. Ashley A. McEvoy
IPO DateMay 15, 2007
HeadquartersActon, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Ashley A. McEvoy | CEO, President & Director | 1971 |
| Ms. Flavia H. Pease | Executive VP & CFO | 1973 |
| Mr. Eric Benjamin | Executive VP & COO | 1983 |
| Mr. John Wodick Kapples J.D. | Senior VP & General Counsel | 1960 |
| Mr. Prem Singh | Senior Vice President of Global Operations | 1977 |
| Mr. Amit Guliani | Senior VP & CTO | — |
| Ms. Clare Trachtman | Vice President of Investor Relations | — |
| Mr. Chuck Medovich | Senior VP and Chief Quality, Regulatory & Compliance Officer | — |
| Ms. Angela Geryak Wiczek | Senior Director of Corporate Communications | — |
| Mr. Philip Hildale | Senior Vice President of Sales & Customer Care | — |
Fundamentals
Valuation
Market cap$9.75B
Price-to-sales ratio3.22
Price-to-book value6.90
Price-earnings ratio26.20
Return on Equity21.00%
Return on Sales0.16%
Return on Assets0.10%
PEG ratio1.11
Earnings Per Share
Earnings Per Share$5.35
Income Statement
Average volume1,722,403
EBITDA$564.00M
1 year high (52w)$354.88
1 year low (52w)$126.40
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



